Showing results (1331-1340 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|September 23, 2015
Seamless Phase IIa/IIb and enhanced dose-finding adaptive designJiacheng Yuan, Herbert Pang, Tiejun Tong, et al.Journal of Biopharmaceutical Statistics|September 23, 2015
Interim analysis based on the weighted log-rank test for delayed treatment effects under staggered patient entryMizuki Yoshida, Yutaka MatsuyamaJournal of Biopharmaceutical Statistics|December 10, 2015
Skew-t partially linear mixed-effects models for AIDS clinical studiesTao LuJournal of Biopharmaceutical Statistics|November 22, 2017
Using previous trial results to inform hypothesis testing of new interventionsChangyu Shen, Xiaochun LiJournal of Biopharmaceutical Statistics|November 22, 2017
Sample size calculations for blinding assessmentVictoria Landsman, Mark Fillery, Howard Vernon, et al.Journal of Biopharmaceutical Statistics|November 28, 2017
Penalty-based approaches to evaluating multiplicity adjustments in clinical trials: Traditional multiplicity problemsGautier Paux, Alex DmitrienkoJournal of Biopharmaceutical Statistics|November 28, 2017
Improving the power to establish clinical similarity in a Phase 3 efficacy trial by incorporating prior evidence of analytical and pharmacokinetic similarityDonglin Zeng, Jean Pan, Kuolung Hu, et al.Journal of Biopharmaceutical Statistics|October 31, 2017
Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A reviewToshimitsu Hamasaki, Scott R Evans, Koko AsakuraJournal of Biopharmaceutical Statistics|September 22, 2017
Estimating the Optimal Personalized Treatment Strategy Based on Selected Variables to Prolong Survival via Random Survival Forest with Weighted BootstrapJincheng Shen, Lu Wang, Stephanie Daignault, et al.Journal of Biopharmaceutical Statistics|September 22, 2017
Biomarker enrichment considerations in oncology early development single-arm studiesHong Tian, Kevin LiuPageof 216